# DeepSight Technology

> DeepSight Technology develops ultrasound imaging and sensor-based instrument guidance for medical procedures. Its FDA-cleared NeedleVue LC1 is a prescription diagnostic ultrasound system in the United States; its broader NeedleVue sensor-guided platform, including LiteCart, Embedded, and Mini concepts, is being developed for precise tool-tip localization.

- **Founded:** 2019
- **Headquarters:** Santa Clara, United States
- **Founders:** Nader Sadrzadeh (Co-founder and CEO), Lan Yang (Co-founder and CTO), Anand Chandrasekher (Co-founder)
- **Products:** NeedleVue LC1 Ultrasound System, NeedleVue LiteCart, NeedleVue Embedded, NeedleVue Mini, On-Point Imaging
- **Notable:** Raised a $25 million Series A in October 2021., Received FDA 510(k) clearance K250381 for the NeedleVue LC1 Ultrasound System on August 1, 2025., Introduced a three-format NeedleVue platform at SIR 2026: LiteCart, Embedded, and Mini.

## Products & services

- **NeedleVue LC1 Ultrasound System** — FDA-cleared U.S. prescription, cart-mounted diagnostic ultrasound system; clearance covers specified conventional and superficial imaging indications, not every proposed NeedleVue guidance feature.
- **NeedleVue LiteCart** — Dedicated interventional ultrasound platform in development for real-time instrument-tip visualization; not yet authorized for sale.
- **NeedleVue Embedded** — Proposed OEM integration of DeepSight sensor guidance into partner medical platforms; not yet authorized for sale.
- **NeedleVue Mini** — Proposed compact add-on for existing ultrasound systems; introduced at SIR 2026 and not yet authorized for sale.
- **On-Point Imaging** — Proposed ultrasound imaging from the perspective of an instrument tip; not yet authorized for sale.

## Achievements

- Raised a $25 million Series A in October 2021.
- Received FDA 510(k) clearance K250381 for the NeedleVue LC1 Ultrasound System on August 1, 2025.
- Introduced a three-format NeedleVue platform at SIR 2026: LiteCart, Embedded, and Mini.

## Latest updates

- **2026-04** — Showcased the NeedleVue LiteCart, Embedded, and Mini platform at SIR 2026; all platforms beyond the LC1 system remained unavailable for sale.
- **2025-10** — Appointed interventional radiologist Bradford Wood vice president of strategic partnerships.
- **2025-08** — Announced FDA 510(k) clearance for the NeedleVue LC1 Ultrasound System.

## Links

- Website: https://www.deepsight.com/
- LinkedIn: https://www.linkedin.com/company/deepsight-technology
- Twitter/X: https://x.com/DeepSightInc
- YouTube: https://www.youtube.com/@DeepSightTechnology
- Instagram: https://www.instagram.com/deepsighttech/
- Facebook: https://www.facebook.com/people/DeepSight-Technology-Inc/100067325952834/

---

Profile page: https://yespress.io/deepsight-technology
Published by YesPress — https://yespress.io
Last updated: 2026-09-30